Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

China · Delayed Price · Currency is CNY

25.65

-0.03 (-0.12%)

Sep 30, 2026, 4:00 PM EDT

SHA:688217 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	156.77	177.26	242.31	258.21	424.3	290.95
Revenue Growth	-24.57%	-26.84%	-6.16%	-39.14%	45.83%	2.11%
Gross Profit	114.47	129.31	179.47	187.65	257.7	212.12
Operating Income	-45.07	-38.8	-19.15	-10.08	72.81	27.04
Net Income	-66.27	-50.38	-15.76	7.93	40.47	47.33
Earnings Per Share	-1.23	-0.91	-0.28	0.14	0.73	0.95
EPS Growth	-	-	-	-80.82%	-23.16%	2.15%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	234.66	225.24	232.68	234.31	294.83	324.88
Total Debt	3.24	2.78	22.42	29.33	13.92	9.53
Net Cash (Debt)	231.43	222.46	210.26	204.98	280.91	315.35
Net Cash Growth	10.93%	5.80%	2.58%	-27.03%	-10.92%	121.80%
Net Cash Per Share	4.30	4.02	3.73	3.62	5.07	6.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	40.77	45.55	59.98	45.1	73.07	77.97
Capital Expenditures	-3.1	-26.76	-39.41	-109.09	-106.57	-95.6
Free Cash Flow	37.67	18.79	20.57	-64	-33.5	-17.63
Free Cash Flow Growth	295.43%	-8.67%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	73.02%	72.95%	74.07%	72.67%	60.73%	72.91%
Operating Margin	-28.75%	-21.89%	-7.90%	-3.91%	17.16%	9.29%
Pretax Margin	-36.83%	-28.62%	-11.75%	-3.64%	16.85%	14.59%
Profit Margin	-42.27%	-28.42%	-6.51%	3.07%	9.54%	16.27%
FCF Margin	24.03%	10.60%	8.49%	-24.79%	-7.90%	-6.06%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.170	0.170	-	0.180
Dividend Per Share Growth	0%	-	-	-
Dividend Yield	0.66%	0.65%	-	0.51%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	252.00	48.54	85.39
Forward PE	-	105.40	76.83	41.61	37.81	-
P/FCF Ratio	37.58	77.41	49.48	-	-	-
PS Ratio	9.03	8.20	4.20	7.74	4.63	13.89